Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2001;37:1124-1128

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krenek, P.
Right arrow Articles by Godfraind, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krenek, P.
Right arrow Articles by Godfraind, T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Blood Pressure Medicines
*Dietary Sodium
*High Blood Pressure
Related Collections
Right arrow Remodeling
Right arrow Cardiovascular Pharmacology
Right arrow Cerebrovascular disease/stroke
Right arrow Other hypertension
Right arrow Hypertrophy
Right arrow Neuroprotectors

(Hypertension. 2001;37:1124.)
© 2001 American Heart Association, Inc.


Scientific Contributions

Lacidipine Prevents Endothelial Dysfunction in Salt-Loaded Stroke-Prone Hypertensive Rats

Peter Krenek; Salvatore Salomone; Jan Kyselovic; Maurice Wibo; Nicole Morel; Théophile Godfraind

From the Laboratoire de Pharmacologie, Université Catholique de Louvain, Brussels, Belgium (P.K., S.S., M.W., N.M., T.G.); and the Department of Pharmacology and Toxicology, Pharmaceutical Faculty of the Comenius University, Bratislava, Slovak Republic (J.K.).

Correspondence to Prof Théophile Godfraind, Université Catholique de Louvain, Laboratoire de Pharmacologie, UCL 54.10, Avenue Hippocrate 54, B-1200 Brussels, Belgium. E-mail godfraind{at}farl.ucl.ac.be

Abstract—Endothelium-dependent vasorelaxation is defective in hypertensive rats, especially in conduit arteries. In the stroke-prone spontaneously hypertensive rat, impaired endothelium-dependent vasorelaxation appears to contribute to the pathogenesis of stroke independent of blood pressure. Because treatment with lacidipine, a long-acting calcium channel blocker, protects against stroke and cardiovascular remodeling in this model, we investigated the effect of this treatment on endothelium-dependent vasorelaxation in the aorta. Stroke-prone rats were exposed to a salt-rich diet (1% NaCl in drinking water) with or without lacidipine (1 mg · kg-1 · d-1) for 6 weeks. A high-sodium diet (1) increased systolic blood pressure, aortic weight, and wall thickness and plasma renin activity (P<0.05); (2) markedly reduced nitric oxide (NO)-mediated, endothelium-dependent relaxation of aortic rings to acetylcholine and the sensitivity to the relaxing effect of S-nitroso-N-acetylpenicillamine, an NO donor (P<0.001); and (3) induced an elevation of preproendothelin-1 mRNA levels in aortic tissue (P<0.01) without affecting endothelial NO synthase mRNA levels. Lacidipine treatment prevented the salt-dependent functional and structural alterations of the aorta, including the overexpression of the preproendothelin-1 gene, and increased endothelial NO synthase mRNA levels in aortic tissue (P<0.01). In conclusion, lacidipine protects stroke-prone hypertensive rats against the impairment of endothelium-dependent vasorelaxation evoked by a salt-rich diet, and this effect may contribute to its beneficial effect against end-organ damage and stroke.


Key Words: calcium channel blockers • calcium antagonists • hypertension, sodium-dependent • endothelium • endothelin • nitric oxide




This article has been cited by other articles:


Home page
Phil Trans R Soc BHome page
T. Godfraind
Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis
Phil Trans R Soc B, December 29, 2005; 360(1464): 2259 - 2272.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Zhu, T. Mori, T. Huang, and J. H. Lombard
Effect of high-salt diet on NO release and superoxide production in rat aorta
Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H575 - H583.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Kagota, A. Tamashiro, Y. Yamaguchi, K. Nakamura, and M. Kunitomo
High Salt Intake Impairs Vascular Nitric Oxide/Cyclic Guanosine Monophosphate System in Spontaneously Hypertensive Rats
J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 344 - 351.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
X. Chen, R. M. Touyz, J. B. Park, and E. L. Schiffrin
Antioxidant Effects of Vitamins C and E Are Associated With Altered Activation of Vascular NADPH Oxidase and Superoxide Dismutase in Stroke-Prone SHR
Hypertension, September 1, 2001; 38(3): 606 - 611.
[Abstract] [Full Text] [PDF]